[ET Net News Agency, 16 September 2024] HSBC Global Research raised the target price for
Innovent Bio (01801) to HKD58 from HKD55 and maintained the "buy" rating.
The research house said it raises 2024-26e revenue estimates by 2-6% and expects
2024-26e revenue of RMB7.9bn, RMB10.0bn and RMB13.2bn, respectively. (rc)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01801 INNOVENT BIO
Nominal 
37.400 -1.450 (-3.732%) Others
16/09/2024 15:55
{I-bank focus}HSBC raises Innovent Bio (01801) to HKD58
Previous︰24/09/2024 10:07 {Block Trade}INNOVENT BIO (01801): 304k shares, or HK$12.49m
Next︰16/09/2024 09:01 {Block Trade}INNOVENT BIO (01801): 370k shares, or HK$16.27m
02/10/2024 13:18 {Block Trade}INNOVENT BIO (01801): 468k shares, or HK$21.84m
02/10/2024 13:16 {Block Trade}INNOVENT BIO (01801): 468k shares, or HK$21.84m
25/09/2024 09:01 {Block Trade}Trading session block trades at 9:00am
11/09/2024 09:01 {Block Trade}Trading session block trades at 9:00am
03/09/2024 10:22 {Block Trade}INNOVENT BIO (01801): 293k shares, or HK$12.45m
| Remark: | Real time quote last updated: 11/11/2024 10:26 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |